Product Information
OXCARBAZEPINE 300 MG TABLET is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1664 per EA under NDC 62559022101. Its NADAC has been published 43 times since Sep 3, 2025.
Strength
300 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559022101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA078005On Market Since
7/15/2025
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 43 times since Sep 3, 2025, and over the history we have for it it has declined 4.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1664 per EA |
|---|---|
| All-time high | $0.1747 (Sep 10, 2025) |
| All-time low | $0.1664 (Jun 17, 2026) |
| 52-week high | $0.1747 |
| 52-week low | $0.1664 |
| Median price | $0.1718 |
| Average price | $0.1706 |
| Largest weekly change | -1.9% (Feb 18, 2026) |
| Weeks tracked | 43 |
| Tracking since | Sep 3, 2025 |
Generic Alternatives
The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by ANI Pharmaceuticals, Inc., is $0.1664 per EA (NDC 62559022101), effective Jun 24, 2026.
How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has declined 4.8%. It has been tracked across 43 weekly CMS publications since Sep 3, 2025.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?
Since Sep 3, 2025, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1664 (Jun 17, 2026) to a high of $0.1747 (Sep 10, 2025), with a median of $0.1718 per EA.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?
9 NADAC-published products share the same active ingredient, strength, and dosage form as OXCARBAZEPINE 300 MG TABLET, but none are currently priced below it.
Who manufactures OXCARBAZEPINE 300 MG TABLET?
OXCARBAZEPINE 300 MG TABLET (NDC 62559022101) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification